Families of trials: The answers to all our questions?

Cerebrovascular Diseases

Volumn 9, Issue 6, 1999, Pages 305-313

  Dennis, Martin ^a,b   Wardlaw, Joanna ^a   Sandercock, Peter ^a   Signorini, David ^a   Warlow, Charles ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Co enrollment; Randomised trials; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; COST; FOLLOW UP; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; STROKE;

BIAS (EPIDEMIOLOGY); CEREBROVASCULAR ACCIDENT; DATA COLLECTION; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; INFORMED CONSENT; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS;

EID: 0032824145     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016003     Document Type: Review

References (15)

1. Saver JL: Coping with an embarassment of riches. How stroke centers may participate in multiple concurrent clinical stroke trials. Stroke 1995;26:1289-1292.
2. Byar D, Schoenfeld DA, Green SB, Amato DA, Davis R, de Gruttola V, Finkelstein DM, Gatsonis C, Gelber RD, Lagakos S, Lefkopoulou M, Tsiatis AA, Zelen M, Peto J, Freedman LS, Gail M, Simon R, Ellenberg SS, Anderson JR, Collins R, Peto R, Peto T: Design considerations for AIDS trials. NEJM 1990;323:1343-1348.
3. Ellenberg SS, Finkelstein DM, Schoenfeld DA: Statistical issues arising in AIDS clinical trials. J Am Stat Assoc 1992;87:562-583.
4. Larntz K, Neaton JD, Wentworth DN, Yurick T: Data analysis issues for protocols with overlapping enrollment. Stat Med 1996;15:2445-2453.
5. Multicentre Acute Stroke Trial (MAST-I) Group: Are thrombolytic and antithrombotic agents safe and useful in acute ischaemic stroke? A randomised controlled trial with streptokinase, aspirin and combination of both treatments. Lancet 1995;346:1509-1514.
6. Third International Study Of Infarct Survival Collaborative Group (ISIS-3): ISIS-3: A randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-770.
7. Ricci S, on behalf of the International Stroke Trialists Collaborative Group: Between country variations in the use of medical treatments for acute stroke. Cerebrovasc Dis 1995;5:272.
8. Lindley RI, Amayo EO, Marshall J, Sandercock PAG, Dennis M, Warlow CP: Acute stroke treatment in UK hospitals: The Stroke Association survey of consultant opinion. J R Coll Physicians Lond 1995;29:479-484.
9. Hussain A, Rodgers H, Barer D: Management of dysphagia in stroke patients: A postal survey. Age Ageing 1995;24(suppl 1):5.
10. Wollman B, D'Agostino HB, Walus-Wigle JR, Easter DW, Beale A: Radiologic, endoscopic and surgical gastrostomy: An institutional evaluation and a meta-analysis of the literature. Radiology 1995;197:699-704.
11. Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GKT: A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ 1996; 312:13-16.
12. Wells PS, Lensing AWA, Hirsh J: Graduated compression stockings in the prevention of postoperative venous thromboembolism: A meta-analysis. Arch Intern Med 1994;154:67-72.
13. European Carotid Surgery Trial Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
14. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,345 patients with acute ischaemic stroke. Lancet 1997;349: 1569-1582.
15. van Gijn J, Warlow CP: Down with stroke scales. Cerebrovasc Dis 1992;2:239-247.